Clinical Trial

Free Fat Flap In Recurrent Neurogenic Thoracic Outlet Syndrome Surgical Treatment

Study acronym: FIRST
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated May 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Thoraco-Brachial Outlet Syndrome (T-BOS) corresponds to the entirety of clinical manifestations related to the compression of the branches of the brachial plexus and/or the subclavian vessels during their passage through the cervico-thoracic region. Following surgery, a recurrence of symptoms occurs in 5% to 30% of operated patients. The treatment of these recurrences primarily relies on conservative therapies, and in case of failure, surgical intervention, particularly neurolysis of the brachial plexus. In order to prevent a new recurrence, it is desirable to cover the neurolyzed brachial plexus with a flap, providing better local vascularization. However, fatty perforating flaps, by avoiding muscle harvesting, reduce donor site sequelae. We aim to investigate, through validated and recommended questionnaires, the impact of covering the neurolyzed brachial plexus with a free fatty flap after neurolysis in the context of recurrent neurological Thoraco-Brachial Outlet Syndrome.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06172101
Lead Sponsor Nantes University Hospital
Conditions Neurogenic Thoracic Outlet Syndrome
Enrollment 20 participants
Start Date 2023-12-18
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-05-18 (estimated)
Updated on ClinicalTrials.gov 2024-07-19